Special Issue "Lipid-Nanoparticle-Mediated Delivery of Small-Molecule and Nucleic Acid-Based Therapeutics"
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 25 May 2024 | Viewed by 990
Special Issue Editor
Interests: nanoparticle to mammalian cells; controlling cellular functions; modulating and imaging neural activity; photophysical interactions of dyes; nanoparticles; liposomes; lipid nanoparticles; nanoparticle-mediated drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lipid nanoparticles (LNPs) have generated tremendous interest in the field of pharmaceutical research as promising vehicles to deliver a variety of therapeutics, including small molecules and nucleic-acid-based medicine. Recently, LNP-based formulations of therapeutics are especially applied to transporting and effectively delivering mRNA vaccines to the cells. LNPs play critical roles in effectively stabilizing, protecting, transporting, and delivering these medicines to cells/tissues. In addition to the tunable size of LNPs, their lipid composition, surface properties, stability, and targeting capacities are critical parameters that need to be controlled and optimized for specific therapeutic needs for the treatment. This Special Issue of Pharmaceuticals focuses on new strategies and advances in LNP-based formulations of therapeutics using various forms of LNPs, including nanostructured LNPs, solid LNPs, and liposomes. We invite researchers to publish their original research and review articles with expert opinions and perspectives in the aforementioned areas.
Dr. Okhil Nag
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
